|
1
|
Bae J and Park JW: Topical delivery of
leflunomide for rheumatoid arthritis treatment: Evaluation of local
tissue deposition of teriflunomide and its anti-inflammatory
effects in an arthritis rat model. Drug Dev Ind Pharm. 27:1–9.
2015.(Epub ahead of print).
|
|
2
|
Smolen JS, Weinblatt ME, van der Heijde D,
Rigby WF, van Vollenhoven R, Bingham CO III, Veenhuizen M, Gill A,
Zhao F, Komocsar WJ, et al: Efficacy and safety of tabalumab, an
anti-B-cell-activating factor monoclonal antibody, in patients with
rheumatoid arthritis who had an inadequate response to methotrexate
therapy: results from a phase III multicentre, randomised,
double-blind study. Ann Rheum Dis. 74:1567–1570. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Westhovens R, Robles M, Ximenes AC,
Wollenhaupt J, Durez P, Gomez-Reino J, Grassi W, Haraoui B, Shergy
W, Park SH, et al: Maintenance of remission following 2 years of
standard treatment then dose reduction with abatacept in patients
with early rheumatoid arthritis and poor prognosis. Ann Rheum Dis.
74:564–568. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chung KC, Kotsis SV, Fox DA, Regan M,
Burke FD, Wilgis EF and Kim HM: Differences between the United
States and the United Kingdom in the treatment of rheumatoid
arthritis: Analyses from a hand arthroplasty trial. Clin Rheumatol.
29:363–367. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kavanaugh A, St Clair EW, McCune WJ,
Braakman T and Lipsky P: Chimeric anti-tumor necrosis factor-alpha
monoclonal antibody treatment of patients with rheumatoid arthritis
receiving methotrexate therapy. J Rheumatol. 27:841–850.
2000.PubMed/NCBI
|
|
6
|
Richter J, Capková K, Hříbalová V,
Vannucci L, Danyi I, Malý M and Fišerová A: Collagen-induced
arthritis: Severity and immune response attenuation using
multivalent N-acetyl glucosamine. Clin Exp Immunol. 177:121–133.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kamada H, Goto M, Matsuura S, Takaoka Y
and Nagai H: Immunopharmacological studies on collagen-induced
arthritis in dark Agouti (DA) rats. Jpn J Pharmacol. 74:313–322.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pimentel TA, Sampaio AL, D'Acquisto F,
Perretti M and Oliani SM: An essential role for mast cells as
modulators of neutrophils influx in collagen-induced arthritis in
the mouse. Lab Invest. 91:33–42. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bonamore A, Barba M, Botta B, Boffi A and
Macone A: Norcoclaurine synthase: Mechanism of an enantioselective
pictet-spengler catalyzing enzyme. Molecules. 15:2070–2078. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng S, Jiang J, Hu P, Zhang JY, Liu T,
Zhao Q and Li BL: A phase I study on pharmacokinetics and
pharmacodynamics of higenamine in healthy Chinese subjects. Acta
Pharmacol Sin. 33:1353–1358. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z, Chen Z, Yang S, Wang Y, Yu L,
Zhang B, Rao Z, Gao J and Tu S: (1)H NMR-based metabolomic analysis
for identifying serum biomarkers to evaluate methotrexate treatment
in patients with early rheumatoid arthritis. Exp Ther Med.
4:165–171. 2012.PubMed/NCBI
|
|
12
|
Luz KR, Furtado RN, Nunes CC, Rosenfeld A,
Fernandes AR and Natour J: Ultrasound-guided intra-articular
injections in the wrist in patients with rheumatoid arthritis: A
double-blind, randomised controlled study. Ann Rheum Dis.
67:1198–1200. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nishiya K, Hisakawa N, Tahara K, Matsumori
A, Ito H, Hashimoto K, Nakatani K and Takatori K: Additive triple
DMARD combination therapy of a low dose of sulfhydryl compounds,
sulfasalazine and methotrexate in the treatment of rheumatoid
arthritis: A clinical trial. Acta Med Okayama. 53:275–279.
1999.PubMed/NCBI
|
|
14
|
Wislowska M and Jakubicz D: Preliminary
evaluation in rheumatoid arthritis activity in patients treated
with TNF-alpha blocker plus methotrexate versus methotrexate or
leflunomide alone. Rheumatol Int. 27:641–647. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang C, Wan L and Liu J: Effect of
Xinfeng capsule on nuclear factor Kappa B/tumor necrosis factor
alpha and transforming growth factor beta 1/Smads pathways in rats
with cardiac injuries induced by adjuvant arthritis. J Tradit Chin
Med. 36:92–100. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma Z, Piao T, Wang Y and Liu J: Astragalin
inhibits IL-1beta-induced inflammatory mediators production in
human osteoarthritis chondrocyte by inhibiting NF-kappaB and MAPK
activation. Int Immunopharmacol. 25:83–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ha YM, Kim MY, Park MK, Lee YS, Kim YM,
Kim HJ, Lee JH and Chang KC: Higenamine reduces HMGB1 during
hypoxia-induced brain injury by induction of heme oxygenase-1
through PI3K/Akt/Nrf-2 signal pathways. Apoptosis. 17:463–474.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee YS, Kang YJ, Kim HJ, Park MK, Seo HG,
Lee JH, Yun-Choi HS and Chang KC: Higenamine reduces apoptotic cell
death by induction of heme oxygenase-1 in rat myocardial
ischemia-reperfusion injury. Apoptosis. 11:1091–1100. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chi PL, Liu CJ, Lee IT, Chen YW, Hsiao LD
and Yang CM: HO-1 induction by CO-RM2 attenuates TNF-α-induced
cytosolic phospholipase A2 expression via inhibition of
PKCα-dependent NADPH oxidase/ROS and NF-κB. Mediators Inflamm.
2014:2791712014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kirino Y, Takeno M, Murakami S, Kobayashi
M, Kobayashi H, Miura K, Ideguchi H, Ohno S, Ueda A and Ishigatsubo
Y: Tumor necrosis factor alpha acceleration of inflammatory
responses by down-regulating heme oxygenase 1 in human peripheral
monocytes. Arthritis Rheum. 56:464–475. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Z, Li M, Wang Y, Wu J and Li J:
Higenamine promotes M2 macrophage activation and reduces Hmgb1
production through HO-1 induction in a murine model of spinal cord
injury. Int Immunopharmacol. 23:681–687. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Torres-Arzayus MI, de Mora J Font, Yuan J,
Vazquez F, Bronson R, Rue M, Sellers WR and Brown M: High tumor
incidence and activation of the PI3K/AKT pathway in transgenic mice
define AIB1 as an oncogene. Cancer Cell. 6:263–274. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pareek TK, Belkadi A, Kesavapany S,
Zaremba A, Loh SL, Bai L, Cohen ML, Meyer C, Liby KT, Miller RH, et
al: Triterpenoid modulation of IL-17 and Nrf-2 expression
ameliorates neuroinflammation and promotes remyelination in
autoimmune encephalomyelitis. Sci Rep. 1:2012011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ha do T, Oh J, Khoi NM, Dao TT, Dung V, Do
TN, Lee SM, Jang TS, Jeong GS and Na M: In vitro and in vivo
hepatoprotective effect of ganodermanontriol against t-BHP-induced
oxidative stress. J Ethnopharmacol. 150:875–885. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ugur M, Yildirim K, Kiziltunc A, Erdal A,
Karatay S and Senel K: Correlation between soluble intercellular
adhesion molecule 1 level and extracellular superoxide dismutase
activity in rheumatoid arthritis: A possible association with
disease activity. Scand J Rheumatol. 33:239–243. 2004. View Article : Google Scholar : PubMed/NCBI
|
